Highlights and Quick Summary
- Stock Based Compensation for the quarter ending October 31, 2022 was $1.11 Million (a -954.65% decrease compared to previous quarter)
- Year-over-year quarterly Stock Based Compensation increased by 1.04%
- Annual Stock Based Compensation for 2022 was $3.07 Million (a 56.21% increase from previous year)
- Annual Stock Based Compensation for 2021 was $1.97 Million (a 115676.47% increase from previous year)
- Annual Stock Based Compensation for 2020 was $1.7 Thousand (a -96.29% decrease from previous year)
- Twelve month Stock Based Compensation ending October 31, 2022 was $3.67 Million (a 19.31% increase compared to previous quarter)
- Twelve month trailing Stock Based Compensation increased by 2.28% year-over-year
Trailing Stock Based Compensation for the last four month:
| 31 Oct '22 | 31 Jul '22 | 30 Apr '22 | 31 Jan '22 |
|---|---|---|---|
| $3.67 Million | $3.07 Million | $3.17 Million | $3.59 Million |
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Stock Based Compensation of BRIACELL THERAP
Most recent Stock Based Compensationof BCTX including historical data for past 10 years.Interactive Chart of Stock Based Compensation of BRIACELL THERAP
BRIACELL THERAP Stock Based Compensation for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $1.11 | $-0.13 | $1.59 | $1.1 | $3.07 |
| 2021 | – | $0.52 | $-0.04 | $2.01 | $1.97 |
| 2020 | – | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | $0.0 | $-0.0 | $-0.0 | $0.05 | $0.05 |
| 2018 | – | $0.0 | $0.19 | $0.01 | $0.37 |
| 2017 | – | $0.01 | $0.11 | $0.06 | $0.21 |
| 2016 | $0.02 | $-0.04 | $0.04 | $0.48 | $0.49 |
| 2015 | $0.01 | $0.07 | $0.14 | $0.28 | $0.5 |
| 2012 | $0.0 | $0.01 | – | – | $0.03 |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology